BioInsights - Sourcing quality raw & starting materials at a reasonable cost during the pandemic

Sourcing quality raw & starting materials at a reasonable cost during the pandemic

Vaccine Insights 2022; 1(6), 315–318

DOI: 10.18609/vac.2022.043

Published: 2 December 2022
Viewpoint
Caryn Fenner


“Enabling LMICs to better face and respond to future pandemics will require changes to how and where raw and starting materials are sourced.”

The COVID-19 pandemic has intensified existing disparities in access to raw and starting materials in low- and middle-income regions. Initiatives from CEPI, GAVI, WHO, and others aim to mitigate the impact, but in the long term, local production of materials is essential for a sustainable vaccine manufacturing ecosystem.